Article
The Myriad Ruling: Six Points Every Biotech CEO Must Consider
The US Supreme Court has recently issued a long-awaited decision in Myriad Genetics, which sent shockwaves through the very foundation of the biotech industry.
Nutter McClennen & Fish LLP
